PortfoliosLab logoPortfoliosLab logo
BZQIY vs. XENE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BZQIY vs. XENE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bezeq Corp Ltd (BZQIY) and Xenon Pharmaceuticals Inc. (XENE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BZQIY achieves a 5.85% return, which is significantly lower than XENE's 39.83% return. Over the past 10 years, BZQIY has underperformed XENE with an annualized return of 5.42%, while XENE has yielded a comparatively higher 23.99% annualized return.


BZQIY

1D
0.00%
1M
-9.35%
6M
-4.03%
YTD
5.85%
1Y
29.30%
3Y*
33.59%
5Y*
21.41%
10Y*
5.42%
ALL TIME*
4.23%

XENE

1D
-2.37%
1M
2.81%
6M
52.82%
YTD
39.83%
1Y
105.48%
3Y*
18.80%
5Y*
29.41%
10Y*
23.99%
ALL TIME*
16.91%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.45K$3.09K$3.90K
$39.88M$82.17M$81.05M

BZQIY vs. XENE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BZQIY
Bezeq Corp Ltd
5.85%65.06%16.21%-13.14%17.10%48.36%20.80%-17.74%-35.39%-16.29%
XENE
Xenon Pharmaceuticals Inc.
39.83%14.34%-14.89%16.81%26.22%103.12%17.32%107.77%123.36%-63.31%

Correlation

The correlation between BZQIY and XENE is -0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.02

Correlation (3Y)
Balances recent behavior with more history.

-0.01

Correlation (5Y)
Shows whether the relationship held over a longer period.

-0.01

Correlation (10Y)
Provides a long-term view across more market conditions.

-0.00

Correlation (All Time)
Calculated using the full available price history since Nov 5, 2014

-0.00

Fundamentals

Market Cap

BZQIY:

$6.20B

XENE:

$6.06B

EPS

BZQIY:

₪2.38

XENE:

-$4.68

PB Ratio

BZQIY:

6.08

XENE:

3.95

Total Revenue (TTM)

BZQIY:

₪8.64B

XENE:

$0.00

Gross Profit (TTM)

BZQIY:

₪6.23B

XENE:

-$78.30M

EBITDA (TTM)

BZQIY:

₪3.73B

XENE:

-$399.62M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BZQIY vs. XENE — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BZQIY
BZQIY Risk / Return Rank: 7373
Overall Rank
BZQIY Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
BZQIY Sortino Ratio Rank: 6464
Sortino Ratio Rank
BZQIY Omega Ratio Rank: 8888
Omega Ratio Rank
BZQIY Calmar Ratio Rank: 7070
Calmar Ratio Rank
BZQIY Martin Ratio Rank: 7777
Martin Ratio Rank

XENE
XENE Risk / Return Rank: 9494
Overall Rank
XENE Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
XENE Sortino Ratio Rank: 9797
Sortino Ratio Rank
XENE Omega Ratio Rank: 9595
Omega Ratio Rank
XENE Calmar Ratio Rank: 9696
Calmar Ratio Rank
XENE Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BZQIY vs. XENE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bezeq Corp Ltd (BZQIY) and Xenon Pharmaceuticals Inc. (XENE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BZQIYXENEDifference
Sharpe ratioReturn per unit of total volatility

-1.13

Sortino ratioReturn per unit of downside risk

-2.90

Omega ratioGain probability vs. loss probability

1.34

1.46

-0.12

Calmar ratioReturn relative to maximum drawdown

1.23

5.75

-4.52

Martin ratioReturn relative to average drawdown

4.34

12.62

-8.28

BZQIY vs. XENE - Sharpe Ratio Comparison

The current BZQIY Sharpe Ratio is 0.62, which is lower than the XENE Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of BZQIY and XENE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BZQIY vs. XENE - Drawdown Comparison

The maximum BZQIY drawdown since its inception was -76.40%, smaller than the maximum XENE drawdown of -90.43%. Use the drawdown chart below to compare losses from any high point for BZQIY and XENE.


Loading charts...

Drawdown Indicators


BZQIYXENEDifference

Max Drawdown

Largest peak-to-trough decline

-76.40%

-90.43%

+14.03%

Max Drawdown (1Y)

Largest decline over 1 year

-23.95%

-18.40%

-5.55%

Max Drawdown (3Y)

Largest decline over 3 years

-41.64%

-43.59%

+1.95%

Max Drawdown (5Y)

Largest decline over 5 years

-43.14%

-43.59%

+0.45%

Max Drawdown (10Y)

Largest decline over 10 years

-73.33%

-77.66%

+4.33%

Current Drawdown

Current decline from peak

-20.28%

-11.68%

-8.60%

Average Drawdown

Average peak-to-trough decline

-32.58%

-39.10%

+6.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.77%

8.37%

-1.60%

Volatility

BZQIY vs. XENE - Volatility Comparison

Bezeq Corp Ltd (BZQIY) has a higher volatility of 17.56% compared to Xenon Pharmaceuticals Inc. (XENE) at 13.42%. This indicates that BZQIY's price experiences larger fluctuations and is considered to be riskier than XENE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BZQIYXENEDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.56%

13.42%

+4.14%

Volatility (6M)

Calculated over the trailing 6-month period

35.14%

46.93%

-11.79%

Volatility (1Y)

Calculated over the trailing 1-year period

47.26%

60.53%

-13.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.49%

67.76%

-5.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.29%

66.27%

-11.98%

Dividends

BZQIY vs. XENE - Dividend Comparison

BZQIY's dividend yield for the trailing twelve months is around 5.69%, while XENE has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BZQIY
Bezeq Corp Ltd
5.69%4.61%5.36%4.77%3.73%0.00%0.00%0.00%4.87%5.78%11.67%8.00%
XENE
Xenon Pharmaceuticals Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

BZQIY vs. XENE - Financials Comparison

This section allows you to compare key financial metrics between Bezeq Corp Ltd and Xenon Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


BZQIY and XENE have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BZQIY has higher volatility (17.56%) compared to XENE (13.42%). In terms of maximum drawdown, BZQIY dropped -76.40% vs XENE's -90.43%.

XENE currently has the higher Sharpe Ratio (1.75 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BZQIY and XENE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer